FR2908044A1 - Complex, useful to prepare composition to treat alopecia, comprises protein, calcium, mineral comprising sodium, potassium, magnesium, phosphorus and sulfur, oilgo-element having selenium, manganese, iron, zinc and copper and acetic acid - Google Patents
Complex, useful to prepare composition to treat alopecia, comprises protein, calcium, mineral comprising sodium, potassium, magnesium, phosphorus and sulfur, oilgo-element having selenium, manganese, iron, zinc and copper and acetic acid Download PDFInfo
- Publication number
- FR2908044A1 FR2908044A1 FR0609730A FR0609730A FR2908044A1 FR 2908044 A1 FR2908044 A1 FR 2908044A1 FR 0609730 A FR0609730 A FR 0609730A FR 0609730 A FR0609730 A FR 0609730A FR 2908044 A1 FR2908044 A1 FR 2908044A1
- Authority
- FR
- France
- Prior art keywords
- complex
- calcium
- sodium
- acetic acid
- selenium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 239000011575 calcium Substances 0.000 title claims abstract description 19
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 19
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 17
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 10
- 239000011707 mineral Substances 0.000 title claims abstract description 10
- 239000011734 sodium Substances 0.000 title claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 title claims abstract description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title claims abstract description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 229910052802 copper Inorganic materials 0.000 title claims abstract description 7
- 239000010949 copper Substances 0.000 title claims abstract description 7
- 229910052742 iron Inorganic materials 0.000 title claims abstract description 7
- 239000011777 magnesium Substances 0.000 title claims abstract description 7
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 7
- 239000011574 phosphorus Substances 0.000 title claims abstract description 7
- 229910052698 phosphorus Inorganic materials 0.000 title claims abstract description 7
- 239000011591 potassium Substances 0.000 title claims abstract description 7
- 229910052700 potassium Inorganic materials 0.000 title claims abstract description 7
- 239000011669 selenium Substances 0.000 title claims abstract description 7
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 7
- 239000011593 sulfur Substances 0.000 title claims abstract description 7
- 229910052717 sulfur Inorganic materials 0.000 title claims abstract description 7
- 239000011701 zinc Substances 0.000 title claims abstract description 7
- 229910052725 zinc Inorganic materials 0.000 title claims abstract description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 title claims abstract description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 title claims abstract description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 title claims abstract description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 239000000203 mixture Substances 0.000 title claims description 20
- 201000004384 Alopecia Diseases 0.000 title claims description 8
- 231100000360 alopecia Toxicity 0.000 title claims description 5
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 title claims description 4
- 239000000052 vinegar Substances 0.000 claims abstract description 18
- 235000021419 vinegar Nutrition 0.000 claims abstract description 18
- 235000013601 eggs Nutrition 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 235000020097 white wine Nutrition 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 239000011572 manganese Substances 0.000 claims abstract description 3
- 229910052748 manganese Inorganic materials 0.000 claims abstract description 3
- 235000010755 mineral Nutrition 0.000 claims description 8
- 239000000341 volatile oil Substances 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 239000011573 trace mineral Substances 0.000 claims description 6
- 235000013619 trace mineral Nutrition 0.000 claims description 6
- 102000002322 Egg Proteins Human genes 0.000 claims description 5
- 108010000912 Egg Proteins Proteins 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 210000004761 scalp Anatomy 0.000 claims description 4
- 229910021532 Calcite Inorganic materials 0.000 claims description 3
- 235000011054 acetic acid Nutrition 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 241000272458 Numididae Species 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 235000001465 calcium Nutrition 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 230000003389 potentiating effect Effects 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 235000020095 red wine Nutrition 0.000 claims description 2
- 235000014101 wine Nutrition 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims 1
- 210000000991 chicken egg Anatomy 0.000 claims 1
- 235000019987 cider Nutrition 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 239000013535 sea water Substances 0.000 claims 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 210000003278 egg shell Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 244000274883 Urtica dioica Species 0.000 description 2
- 235000009108 Urtica dioica Nutrition 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 230000002879 macerating effect Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000378544 Melaleuca quinquenervia Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 240000004901 Rhus typhina Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 240000002493 Smilax officinalis Species 0.000 description 1
- 235000008981 Smilax officinalis Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 241000256618 Trichogramma Species 0.000 description 1
- 240000001260 Tropaeolum majus Species 0.000 description 1
- 235000004424 Tropaeolum majus Nutrition 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229940095714 cider vinegar Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 210000005132 reproductive cell Anatomy 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000000998 shell membrane Anatomy 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/23—Sulfur; Selenium; Tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
-1- La présente invention est relative à un nouveau complexe à base deThe present invention relates to a novel complex based on
protéines et calcium de la coquille d'oeuf, de minéraux, d'oligo-éléments et acide acétique. Ce nouveau complexe d'origine naturelle se caractérise en ce qu'il est constitué de protéines provenant essentiellement de la coquille d'oeuf et de calcium provenant de la calcite de la coquille d'oeuf. Conformément à l'invention, les protéines et le calcium sont dans un rapport protéines/calcium variant de 0,8 à 0,9. Conformément à l'invention, le complexe contient : - protéines : 0,40 à 0,45% - calcium : 0,50 à 0,51% - minéraux : sodium, potassium, magnésium, phosphore, soufre dont les teneurs respectives sont : - sodium 1,70 à 2,50% - potassium 0,11% - magnésium 0,05% - phosphore 0,055 à 0,060% - soufre 0,10% -oligo-éléments : sélénium, manganèse, fer, zinc, cuivre dont 20 les teneurs respectives sont : - sélénium 29,0ppm - manganèse 4,5ppm - fer 4,4ppm - zinc 2,0ppm 25 - cuivre 0,4ppm - acide acétique : 4,70% Selon un mode de réalisation avantageux de l'objet de l'invention, l'acide acétique est ajouté sous forme de vinaigre. Selon un mode de réalisation avantageux, le sodium est ajouté sous 30 forme de sel marin. La présente invention est relative à la préparation du complexe résultant de la combinaison entre eux, d'oeufs de poule crus munis de leurs coquilles, de vinaigre de vin et de sel gris marin. 2908044 -2- 1) On emploie les ingrédients dans les proportions suivantes : - oeufs de poule 3 - sel gris marin 80 g - vinaigre de vin blanc 7 1 L 5 2) On opère ainsi : remplir une cuve de vinaigre de vin blanc, ajouter le sel, faire dissoudre par agitation. Ajouter les oeufs crus munis de leurs coquilles en les immergeant un à un délicatement pour ne pas les casser. Laisser reposer un mois sans agiter. Retirer les oeufs un à un délicatement, cette fois afin de ne pas perforer les membranes coquillières. 10 Filtrer la solution ainsi obtenue. Si on le souhaite, on peut obtenir un complexe conforme à la présente invention en utilisant des oeufs de pintades ainsi que du vinaigre de vin rouge ou de cidre. Selon l'invention, les matières premières sont d'origine 15 exclusivement naturelle et apportent en un mélange équilibré, protéines et calcium provenant essentiellement de la coquille auxquels viennent s'ajouter les minéraux : sodium, potassium, magnésium, phosphore, soufre et les oligo-éléments : sélénium, manganèse, fer, zinc, cuivre provenant essentiellement du vinaigre et du sel marin. protein and calcium from eggshell, minerals, trace elements and acetic acid. This new complex of natural origin is characterized in that it consists of proteins derived mainly from the eggshell and calcium from the calcite of the eggshell. According to the invention, the proteins and calcium are in a protein / calcium ratio ranging from 0.8 to 0.9. According to the invention, the complex contains: - proteins: 0.40 to 0.45% - calcium: 0.50 to 0.51% - minerals: sodium, potassium, magnesium, phosphorus, sulfur whose respective contents are: - sodium 1.70 to 2.50% - potassium 0.11% - magnesium 0.05% - phosphorus 0.055 to 0.060% - sulfur 0.10% - trace elements: selenium, manganese, iron, zinc, copper of which 20 the respective contents are: selenium 29.0 ppm-manganese 4.5ppm iron 4.4ppm zinc 2.0 ppm 25-copper 0.4 ppm acetic acid 4.70% According to an advantageous embodiment of the object of the invention, acetic acid is added in the form of vinegar. According to an advantageous embodiment, the sodium is added in the form of sea salt. The present invention relates to the preparation of the complex resulting from the combination between them, raw chicken eggs with their shells, wine vinegar and sea salt. 2908044 -2- 1) The ingredients are used in the following proportions: - chicken eggs 3 - marine gray salt 80 g - white wine vinegar 7 1 L 5 2) The procedure is as follows: fill a vat with white wine vinegar, add salt, dissolve by stirring. Add the raw eggs with their shells, immersing them one by one so as not to break them. Leave to rest for a month without shaking. Remove the eggs one by one delicately, this time so as not to perforate the shell membranes. Filter the solution thus obtained. If desired, a complex according to the present invention can be obtained using guinea fowl eggs as well as red wine or cider vinegar. According to the invention, the raw materials are of exclusively natural origin and provide in a balanced mixture, proteins and calcium essentially from the shell, to which are added the minerals: sodium, potassium, magnesium, phosphorus, sulfur and oligo -Selenium, manganese, iron, zinc, copper mainly from vinegar and sea salt.
L'étude de la composition de la coquille d'oeuf montre qu'elle renferme en moyenne 3,3% de protéines constituant sa trame. Ces protéines jouent un rôle majeur dans les processus de la calcification de la coquille en faisant cristalliser environ 95,1% de minéraux, essentiellement des cristaux de carbonate de calcium sous forme de calcite. Les Protéines et le calcium absorbé au sein de la matrice organique sont donc très étroitement impliqués dans la construction de la microstructure cristalline de la coquille laquelle contribue à sa solidité. Protéines, calcium, sels minéraux et oligo-éléments sont présents à l'état naturel dans notre organisme et sont indispensables à son bon fonctionnement. Le calcium est un acteur clé. On le retrouve impliqué dans de multiples actions métaboliques intervenant notamment dans la construction de la structure de la peau. 2908044 -3- Actuellement de nombreuses théories tentent de rendre compte de l'ensemble des phénomènes complexes intervenant dans les processus qui conduisent au vieillissement et à la détérioration du fonctionnement des cellules d'organes vitaux, les poussant dans certaines conditions 5 défavorables au suicide cellulaire (apoptose). D'après les scientifiques, les carences nutritionnelles ou l'hyperproduction de radicaux libres seraient aussi responsables d'un grand nombre de dommages causés aux cellules. On parle de sénescence réplicative et métabolique. Qu'ils soient apportés par l'environnement 10 (pollution, fumée de cigarette, rayonnements...) ou engendrés par les cellules au cours de leurs réactions métaboliques, les radicaux libres peuvent perturber la réplication de l'ADN lors des divisions cellulaires et réduire leur capacité à se régénérer. Ils peuvent aussi détruire les membranes cellulaires, déformer les protéines cellulaires chargées du 15 transport du calcium lequel se trouve dans l'incapacité de jouer son rôle de messager intercellulaire. Les cellules ne communiquent plus, perdent leur cohésion, se désorganisent lésant gravement les tissus. Au niveau de la peau, l'ensemble de ces bouleversements conduisent à l'accélération du vieillissement cutané et dans certaines 20 conditions à l'altération des tissus et l'apparition de maladies, dermatoses, eczéma, psoriasis, prurit, alopécie. Il est maintenant établi qu'une corrélation existe entre le vieillissement cellulaire et l'alopécie. Les cellules reproductrices des follicules pileux sont normalement programmées pour se régénérer et faire 25 naître de nouveaux cheveux d'une manière ininterrompue grâce à des cycles de pousse fixés entre 25 à 30 cycles lesquels ayant une durée de 2 à 5 ans, sont en nombre suffisant pour renouveler la chevelure pendant toute une vie. Avec l'âge, les récepteurs hormonaux de ces organes cibles deviennent particulièrement sensibles à l'action nocive de la 30 dihydrotestostérone formée à partir de la testostérone sous l'effet de la 5 alpha réductase. Le ralentissement du rythme des divisions cellulaires et la dégradation du fonctionnement des follicules pileux se traduisent par la diminution des cycles de pousse qui rapidement s'épuisent passant de 2908044 -4- quelques années à quelques mois. La chevelure s'éclaircit et si on n'enraye pas la chute, on assiste à la perte définitive des cheveux. Selon l'invention, le complexe est spécialement conçu pour être appliqué sur le cuir chevelu et la peau. Les actifs : protéines, calcium, 5 minéraux, oligo-éléments et acide acétique sont sous forme d'une solution de pH 5,5 favorisant leur absorption cutanée et biodisponibilité. Par sa composition, le complexe apporte au coeur des cellules endommagées ou en panne tous les éléments nutritifs nécessaires au rétablissement du fonctionnement cellulaire. Il est capable de reproduire 10 au niveau des structures de la peau, les mécanismes de solidité naturelle résultant de l'affinité des protéines et du calcium dans la formation de la coquille. En rétablissant le métabolisme du calcium, le complexe renforce la cohésion des tissus cutanés et aide à lutter contre le vieillissement cutané. The study of the composition of the eggshell shows that it contains on average 3.3% of proteins constituting its frame. These proteins play a major role in the processes of calcification of the shell by crystallizing about 95.1% of minerals, mainly calcium carbonate crystals in the form of calcite. Proteins and calcium absorbed within the organic matrix are therefore very closely involved in the construction of the crystalline microstructure of the shell which contributes to its strength. Protein, calcium, mineral salts and trace elements are naturally present in our body and are essential for its proper functioning. Calcium is a key player. It is found involved in multiple metabolic actions involved in particular in the construction of the structure of the skin. Currently, many theories attempt to account for all the complex phenomena involved in the processes that lead to aging and deterioration of the functioning of vital organ cells, pushing them under certain unfavorable conditions for cell suicide. (apoptosis). According to scientists, nutritional deficiencies or hyperproduction of free radicals would also be responsible for a large number of cell damage. We talk about replicative and metabolic senescence. Whether brought by the environment 10 (pollution, cigarette smoke, radiation ...) or generated by the cells during their metabolic reactions, free radicals can disrupt the replication of DNA during cell division and reduce their ability to regenerate. They can also destroy cell membranes, deform cellular proteins responsible for calcium transport which is unable to play its role of intercellular messenger. The cells do not communicate anymore, lose their cohesion, disorganize seriously injuring the tissues. At the level of the skin, all of these changes lead to the acceleration of cutaneous aging and in certain conditions to the deterioration of the tissues and the appearance of diseases, dermatoses, eczema, psoriasis, pruritus, alopecia. It is now established that a correlation exists between cellular aging and alopecia. The reproductive cells of the hair follicles are normally programmed to regenerate and to give rise to new hair in an uninterrupted manner thanks to growth cycles set between 25 to 30 cycles which have a duration of 2 to 5 years, are sufficient in number. to renew the hair for a lifetime. With age, the hormonal receptors of these target organs become particularly sensitive to the deleterious action of dihydrotestosterone formed from testosterone by the action of 5 alpha reductase. Slowing down the rate of cell divisions and the deterioration of the functioning of the hair follicles results in a decrease in growth cycles which rapidly run out from 2908044 -4- a few years to a few months. The hair clears and if we do not stop the fall, we witness the permanent loss of hair. According to the invention, the complex is specially designed to be applied to the scalp and skin. The active ingredients: proteins, calcium, minerals, trace elements and acetic acid are in the form of a pH 5.5 solution favoring their dermal absorption and bioavailability. By its composition, the complex brings to the heart of the cells damaged or broken down all the nutrients necessary for the restoration of cellular functioning. It is able to reproduce at the level of the structures of the skin, the mechanisms of natural solidity resulting from the affinity of proteins and calcium in the formation of the shell. By restoring the calcium metabolism, the complex reinforces the cohesion of the cutaneous tissues and helps fight against skin aging.
15 La présente invention a pour objet la formulation de compositions utilisées dans le traitement de l'alopécie, des affections de la peau et du cuir chevelu. Les compositions se caractérisent en ce qu'elles contiennent le complexe associé ou non à un ou plusieurs composants actifs destinés à 20 potentialiser ses effets tels que les huiles essentielles et/ou des extraits végétaux et peuvent donc être proposées selon le besoin spécifique à traiter, dans une ou plusieurs de leurs indications. Ainsi les formulations des compositions sont diverses et requièrent la connaissance et l'expérience de l'homme de métier.The present invention relates to the formulation of compositions used in the treatment of alopecia, skin and scalp conditions. The compositions are characterized in that they contain the complex associated or not with one or more active components intended to potentiate its effects such as essential oils and / or plant extracts and can therefore be proposed according to the specific need to be treated, in one or more of their indications. Thus the formulations of the compositions are diverse and require the knowledge and experience of the skilled person.
25 L'invention est illustrée sans n'être aucunement limitée à l'aide des exemples suivants qui décrivent la formulation d'une composition capillaire antichute assortie d'un compte-rendu d'expérimentations cliniques et la formulation d'une composition antiprurigineuse utilisée dans le traitement de l'eczéma.The invention is illustrated without being limited in any way by the following examples which describe the formulation of a hair fall arrest composition together with a report of clinical experiments and the formulation of an antipruritic composition used in the treatment of eczema.
30 Exemple 1 : Lotion capillaire antichute a)- Préparer un vinaigre de plantes en faisant macérer pendant un mois dans du vinaigre de vin blanc 7 : 5g d'ortie piquante racines, 5g d'ortie piquante feuilles, 5g de bardane 2908044 -5- 5g de thym fleurs, 5g de capucine semences, pour un litre de vinaigre. b)- Procéder selon l'invention, à l'obtention du complexe de plantes par combinaison du sel, des oeufs et du vinaigre de plantes dans les proportions suivantes : -oeufs de poule 3 - sel gris marin 80g - vinaigre de plantes iL c)-Procéder à la formulation - huile essentielle de lavande 0,40g -alkylphénol-polyglycoléther 5,OOg - composition parfumante 1,OOg -complexe de plantes 100,OOg La démonstration de l'efficacité de la composition capillaire selon l'exemple repose sur des expérimentations cliniques réalisées à l'hôpital 15 Saint Louis à Paris dans le service des maladies du cuir chevelu. L'étude de l'impact sur la formule pilaire a été réalisée par la méthode des trichogrammes. Les patients, hommes ou femmes ont été sélectionnés d'après une tendance marquée à la chute des cheveux. 40 cas ont été retenus : 22 personnes de sexe masculin, 18 de sexe féminin, 20 âgées de 13 à 65 ans. Les résultats obtenus sont remarquables. Au terme de l'étude clinique et l'anamnèse, il est constaté un arrêt de la chute des cheveux dans 80% des cas. A l'analyse des trichogrammes, l'effet antichute est objectivé par la repousse des cheveux pour un tiers des cas dans la zone 25 frontale et pour la moitié des cas dans les zones temporales. Les femmes obtiennent aussi de bons résultats lorsqu'elles sont en période de ménopause ou déjà ménopausées. La formule s'emploie aussi bien chez les hommes que chez les femmes. Du fait aussi de l'efficacité de la formule sur la séborrhée dans 70% 30 des cas, le prurit dans 80% et pityriasis dans 82% des cas, la composition a été proposée dans ces indications; qu'elles soient associées ou isolées. 5 10 2908044 -6- Exemple 2 : Pommade utilisée dans le traitement du prurit et de l'eczéma. 5 a)- Préparer un vinaigre de plantes en faisant macérer pendant un mois dans du vinaigre de vin blanc 7 : 5g de pensée sauvage fleurs, 5g de salsepareille racines, 5g d'orme pyramidale écorces, 5g de genièvre 10 baies, 5g d'aspérule odorante, pour un litre de vinaigre. b)- Procéder selon l'invention, à l'obtention du complexe de plantes par combinaison du sel, des oeufs et du vinaigre de plantes dans les proportions suivantes : - oeufs de poule 3 - sel gris marin 80g 0,40g - vinaigre de plantes iL c)-Procéder à la formulation - huile essentielle de lavande 15 - huile essentielle de géranium 0,15g - huile essentielle de niaouli 0,10g - huile essentielle de sauge 0,10g 20 - complexe de plantes 25,OOg - huile d'olive 25,OOg - graisse de laine qsp 100,OOgExample 1: Anti-hair loss hair lotion a) - Prepare a vinegar of plants by macerating for one month in white wine vinegar 7: 5g of nettle spiny roots, 5g of nettle pungent leaves, 5g of burdock 2908044 -5- 5g of thyme flowers, 5g of nasturtium seeds, for a liter of vinegar. b) - Proceed according to the invention, to obtain the complex of plants by combining the salt, eggs and vinegar of plants in the following proportions: - chicken eggs 3 - sea salt 80g - plant vinegar iL c ) -Procede the formulation - lavender essential oil 0,40g -alkylphenol-polyglycolether 5, OOg - perfume composition 1, OOg -complexe of plants 100, OOg The demonstration of the effectiveness of the hair composition according to the example is based on clinical trials carried out at the Saint Louis Hospital in Paris in the department of scalp diseases. The study of the impact on the hair formula was performed using the trichogramma method. Patients, men or women, were selected according to a marked tendency to hair loss. 40 cases were selected: 22 males, 18 females, 20 13 to 65 years old. The results obtained are remarkable. At the end of the clinical study and the anamnesis, it is found a stop of hair loss in 80% of cases. In the trichogram analysis, the fall arrest effect is objectified by hair regrowth for one-third of the cases in the frontal area and for half of the cases in the temporal zones. Women also perform well when they are menopausal or already menopausal. The formula is used for both men and women. Because of the effectiveness of the formula on seborrhea in 70% of cases, pruritus in 80% and pityriasis in 82% of cases, the composition was proposed in these indications; whether they are associated or isolated. Example 2: Ointment used in the treatment of pruritus and eczema. 5 a) - Prepare a vinegar of plants by macerating for a month in white wine vinegar 7: 5g of wild thought flowers, 5g of sarsaparilla roots, 5g of elm pyramidal barks, 5g of juniper 10 berries, 5g of sweet woodruff, for a liter of vinegar. b) - Proceed according to the invention, to obtain the complex of plants by combining the salt, eggs and vinegar of plants in the following proportions: - chicken eggs 3 - marine gray salt 80g 0,40g - vinegar plants iL c) -Process the formulation - essential oil of lavender 15 - essential oil of geranium 0,15g - essential oil of niaouli 0,10g - essential oil of sage 0,10g 20 - complex of plants 25, OOg - oil of d olive 25, OOg - wool fat qs 100, OOg
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609730A FR2908044B1 (en) | 2006-11-07 | 2006-11-07 | NEW COMPLEX OF NATURAL ORIGIN BASED ON PROTEINS AND CALCIUM OF THE EGG SHELL, MINERALS, OLIGO-ELEMENTS AND ACETIC ACID, AND ITS USE FOR MEDICAL AND COSMETIC PURPOSES. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0609730A FR2908044B1 (en) | 2006-11-07 | 2006-11-07 | NEW COMPLEX OF NATURAL ORIGIN BASED ON PROTEINS AND CALCIUM OF THE EGG SHELL, MINERALS, OLIGO-ELEMENTS AND ACETIC ACID, AND ITS USE FOR MEDICAL AND COSMETIC PURPOSES. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2908044A1 true FR2908044A1 (en) | 2008-05-09 |
FR2908044B1 FR2908044B1 (en) | 2009-11-06 |
Family
ID=38513106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0609730A Active FR2908044B1 (en) | 2006-11-07 | 2006-11-07 | NEW COMPLEX OF NATURAL ORIGIN BASED ON PROTEINS AND CALCIUM OF THE EGG SHELL, MINERALS, OLIGO-ELEMENTS AND ACETIC ACID, AND ITS USE FOR MEDICAL AND COSMETIC PURPOSES. |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2908044B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109562283A (en) * | 2016-08-12 | 2019-04-02 | 荷兰联合利华有限公司 | Hiar treatment compositions |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2533437A1 (en) * | 1982-09-28 | 1984-03-30 | Hecmati Michel | Dentifrice composition containing exclusively natural products and which has the appearance of a black gel or paste |
GB2218906A (en) * | 1988-05-27 | 1989-11-29 | Anne Mcmanus | Medicament for treatment of skin disorders |
US5662954A (en) * | 1994-07-05 | 1997-09-02 | Joiner; Margie | Method for preparing mineral-enriched citrate compositions |
WO1998025586A1 (en) * | 1996-12-10 | 1998-06-18 | Patricia Dupuy | Preparation for dermatological use |
US6036966A (en) * | 1998-02-17 | 2000-03-14 | Youssefyeh; Rena T. | Skin treatment compositions comprising protein and enzyme extracts |
JP2002212069A (en) * | 2001-12-10 | 2002-07-31 | Noevir Co Ltd | Skin care perparation |
JP2004229534A (en) * | 2003-01-29 | 2004-08-19 | Yukio Hasebe | Hydrolyzed eggshell membrane-containing drink |
US20040180025A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
-
2006
- 2006-11-07 FR FR0609730A patent/FR2908044B1/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2533437A1 (en) * | 1982-09-28 | 1984-03-30 | Hecmati Michel | Dentifrice composition containing exclusively natural products and which has the appearance of a black gel or paste |
GB2218906A (en) * | 1988-05-27 | 1989-11-29 | Anne Mcmanus | Medicament for treatment of skin disorders |
US5662954A (en) * | 1994-07-05 | 1997-09-02 | Joiner; Margie | Method for preparing mineral-enriched citrate compositions |
WO1998025586A1 (en) * | 1996-12-10 | 1998-06-18 | Patricia Dupuy | Preparation for dermatological use |
US6036966A (en) * | 1998-02-17 | 2000-03-14 | Youssefyeh; Rena T. | Skin treatment compositions comprising protein and enzyme extracts |
JP2002212069A (en) * | 2001-12-10 | 2002-07-31 | Noevir Co Ltd | Skin care perparation |
JP2004229534A (en) * | 2003-01-29 | 2004-08-19 | Yukio Hasebe | Hydrolyzed eggshell membrane-containing drink |
US20040180025A1 (en) * | 2003-03-12 | 2004-09-16 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
WO2004080428A2 (en) * | 2003-03-12 | 2004-09-23 | New Life Resources, Llc | Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations |
Non-Patent Citations (1)
Title |
---|
"Hair tonic composition comprising egg and rice vinegar - useful for promoting hair growth, and as a hair treatment", 18 May 1999, DERWENT, XP002223535 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109562283A (en) * | 2016-08-12 | 2019-04-02 | 荷兰联合利华有限公司 | Hiar treatment compositions |
CN109562283B (en) * | 2016-08-12 | 2022-11-08 | 联合利华知识产权控股有限公司 | Hair treatment composition |
Also Published As
Publication number | Publication date |
---|---|
FR2908044B1 (en) | 2009-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2771288A1 (en) | HAIR TREATMENT COMPOSITION AND MANUFACTURING METHOD THEREOF | |
EP3370833B1 (en) | Synergistic extract of palmaria palmata | |
JP2024052921A (en) | Compositions containing products of lactic acid bacteria, methods for producing equol, and methods for producing compositions containing products of lactic acid bacteria | |
Ku et al. | Combination of Korean red ginseng extract and hydrogen-rich water improves spermatogenesis and sperm motility in male mice | |
FR2597337A2 (en) | Cosmetic for retarding skin ageing and method of application | |
JP2015129112A (en) | Catalase expression-inducing agents | |
FR2546754A1 (en) | COSMETIC AGENTS FOR THE CARE OF HEALTH AND BODY | |
FR2908044A1 (en) | Complex, useful to prepare composition to treat alopecia, comprises protein, calcium, mineral comprising sodium, potassium, magnesium, phosphorus and sulfur, oilgo-element having selenium, manganese, iron, zinc and copper and acetic acid | |
Rivero et al. | Antioxidant activity in vivo and in vitro of Halimeda incrassata aqueous extracts | |
JP2011514900A (en) | Pharmaceutical composition for preventing liver damage or improving liver function, comprising ena active mineral A active water as an active ingredient | |
AU2021275500B2 (en) | Protein hydrolysate of Moringa Peregrina Seed Cake for Its Application as a Medicament, Process for Obtaining Same and Pharmaceutical and Dermatological Compositions | |
FR2741266A1 (en) | Cosmetic and therapeutic compositions contg a haemocyanin | |
LU87171A1 (en) | COSMETIC COMPOSITIONS REGENERATING THE SKIN AND THEIR PREPARATION METHOD | |
CN107961209A (en) | A kind of skin care item of whitening anti-aging and preparation method thereof | |
WO2009086934A1 (en) | Composition for treating scalp and skin | |
EP2139503B1 (en) | Cosmetic and dermatological compositions based on algae extracts | |
FR2712810A1 (en) | Padina pavonica-type algae compositions or extracts for improving calcium fixation by biological tissues, their uses. | |
JP3723892B2 (en) | Reduced antioxidant and method for producing the same | |
FR2582485A1 (en) | Composition for supplementing and balancing animal feeding and method for preparing it | |
KR20060038969A (en) | Processed foods with the theme of seaweed (whole grain powder) and kelp | |
KR102653697B1 (en) | Composition for improving scalp and hair loss and manufacturing thereof | |
FR3024660A1 (en) | NUTRIENT COMPLEX FOR PRODUCING A NUTRIENT COSMETIC COMPOSITION BASED ON MARINE SOURCE WATER AND ALGAE EXTRACT. | |
FR3004344A1 (en) | EXTERNALLY PRODUCED AGAINST HAIR DROP AND USE OF THIS PRODUCT | |
KR101020161B1 (en) | Bath additive composition containing capsaicin | |
WO2022004631A1 (en) | Composition for improving skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 10 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |